NASDAQ: ICPT
Intercept Pharmaceuticals Inc Earnings & Revenue

ICPT past revenue growth

How has ICPT's revenue growth performed historically?
Company
17.75%
Industry
960.59%
Market
42.08%
ICPT's revenue has grown slower... subscribe to Premium to read more.
Performance
ICPT's revenue has grown faster... subscribe to Premium to read more.
Performance
ICPT's revenue growth is slowing... subscribe to Premium to read more.
Performance

ICPT earnings and revenue history

Current Revenue
$354.3M
Current Earnings
-$107.3M
Current Profit Margin
-30.3%

ICPT Return on equity

Current Company
N/A
Current Industry
8.9%
Current Market
93.9%

ICPT Return on assets

Current Company
-20%
Current Industry
3%
ICPT is generating lower Return... subscribe to Premium to read more.
Performance

ICPT Return on capital employed

Current Company
-14.75%
Current Industry
10.9%
ICPT has gotten more efficient... subscribe to Premium to read more.
Performance

ICPT earnings dates

Next earnings date
Feb 23, 2022

Intercept Pharmaceuticals Earnings & Revenue FAQ

What were ICPT's earnings last quarter?

On Invalid Date, Intercept Pharmaceuticals (NASDAQ: ICPT) reported Q3 2021 earnings per share (EPS) of -$0.11, up 94.53% year over year. Total Intercept Pharmaceuticals earnings for the quarter were -$3.63 million. In the same quarter last year, Intercept Pharmaceuticals's earnings per share (EPS) was -$2.01.

What was ICPT's earnings growth in the past year?

As of Q1 2022, Intercept Pharmaceuticals's earnings has grown null year over year. Intercept Pharmaceuticals's earnings in the past year totalled -$107.29 million.

What is ICPT's earnings date?

Intercept Pharmaceuticals's earnings date is Invalid Date. Add ICPT to your watchlist to be reminded of ICPT's next earnings announcement.

What was ICPT's revenue last quarter?

On Invalid Date, Intercept Pharmaceuticals (NASDAQ: ICPT) reported Q3 2021 revenue of $92.83 million up 16.73% year over year. In the same quarter last year, Intercept Pharmaceuticals's revenue was $79.52 million.

What was ICPT's revenue growth in the past year?

As of Q1 2022, Intercept Pharmaceuticals's revenue has grown 17.75% year over year. This is 942.84 percentage points lower than the US Biotechnology industry revenue growth rate of 960.59%. Intercept Pharmaceuticals's revenue in the past year totalled $354.33 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.